Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 25.9 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 60.7 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 54.1 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 38.7 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 33.5 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 86.6 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 18.9 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 22.5 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 0.0 | BCD100427B001 | 20.8 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 0.5 | BCD100427B003 | 34.5 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 1.0 | BCD100427B007 | 74 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 2.0 | BCD100427B011 | 39.3 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 4.0 | BCD100427B015 | 39.1 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 8.0 | BCD100427B019 | 20.3 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 12.0 | BCD100427B023 | 48.7 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | C | 24.0 | BCD100427B027 | 10.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 43.9 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 38 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 40.6 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 36.5 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 111 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 8.52 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 30.6 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 0.5 | BCD100427B004 | 64 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 1.0 | BCD100427B008 | 38.2 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 2.0 | BCD100427B012 | 83.1 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 4.0 | BCD100427B016 | 28.9 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 8.0 | BCD100427B020 | 19.7 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 12.0 | BCD100427B024 | 103 | pmol/sample |
| - | PE(34:3e)/PE(34:2p) | 25OH-Chol | 24.0 | BCD100427B028 | 6.44 | pmol/sample |